KARAKTERISTIK DAN RIWAYAT PENGGUNAAN KB PADA PASIEN KANKER SERVIKS UTERI DI POLIKLINIK GINEKOLOGI RSUP DR KARIADI SEMARANG

Karsi, G2A216060 (2018) KARAKTERISTIK DAN RIWAYAT PENGGUNAAN KB PADA PASIEN KANKER SERVIKS UTERI DI POLIKLINIK GINEKOLOGI RSUP DR KARIADI SEMARANG. Sarjana / Sarjana Terapan (S1/D4) thesis, ["eprint_fieldopt_institution_Universitas Muhammadiyah Semarang" not defined].

Preview	Text MANUSCRIPT.pdf Download (2MB) | Preview
Preview	Text ABSTRAK.pdf Download (2MB) | Preview
Preview	Text BAB I.pdf Download (2MB) | Preview
Preview	Text BAB II.pdf Download (2MB) | Preview
	Text BAB III.pdf Restricted to Repository staff only Download (2MB) | Request a copy
	Text BAB IV.pdf Restricted to Repository staff only Download (2MB) | Request a copy
Preview	Text BAB V.pdf Download (2MB) | Preview
Preview	Text DAFTAR PUSTAKA.pdf Download (2MB) | Preview

Abstract

The World Health Organization (WHO) states that worldwide there are 490,000 cases of cervical cancer and result in 240,000 deaths annually. Some of the supporting factors that can lead to cervical cancer include age at first sexual intercourse, parity, family history with cervical cancer, and a history of use of birth control. The purpose of this study is to describe the characteristics of cervical cancer patients in the Gynecology Polyclinic of Dr. Kariadi Hospital. The type of research used is descriptive survey. This study was conducted on December 5, 2017 - January 3, 2018 at the Gynecology Polyclinic of Dr. Kariadi Hospital with purposive sampling sampling technique of 120 respondents. The results showed that the age of cervical cancer patients was youngest 29 years, the oldest 75 years. Age first intercourse youngest 12 years old. History of parity of patients who have not had children and children at most amounted to 6. Most of the study respondents have a family history with cervical cancer as much as 55.8%. Most of the study respondents had a family history of 3 month injections of 60.8%. At least time to use KB for 1 year and 26 years old. Progesterone and estrogen hormone imbalances used for hormonal contraceptives can cause cervical cancer due to cell mutations as the division increases due to cell proliferation by increased estrogen and progesterone and estrogen and progesterone hormones stimulate the growth of cancer stem cells. Based on existing data is expected the hospital can inform the public about the risk factors associated with the incidence of cervical cancer uteri, so that people understand and ultimately perform promotive and preventive actions.

Actions (login required)

View Item